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Abstract
Depression and type 2 diabetes (T2D) are common comorbid diseases and highly prevalent in the clinical setting with an
unclarified mechanism. Zucker diabetic fatty (ZDF, fa/fa) rats natively develop T2D with hyperglycemia and
hyperinsulinemia. Here we studied whether ZDF rats also innately develop depression, what a correlation is between
depression and T2D, whether insulin receptor (IR) expression is involved in, and whether transcutaneous auricular vagus
nerve stimulation (taVNS) would be beneficial in amelioration of the comorbidity. Six week old male ZDF and Zucker lean
(ZL, fa/+) littermates were randomly divided into naı ¨ve (ZDF, n=6; ZL, n=7) and taVNS (ZDF-taVNS, n=8; ZL-taVNS, n=6)
groups. Once daily 30 min-taVNS sessions were administrated under anesthesia for 34 consecutive days in taVNS groups.
Blood glucose levels were tested weekly, and plasma glycosylated hemoglobin (HbAlc) level and immobility time in forced
swimming test were determined on day 35 in all groups. The expression of insulin receptor (IR) in various tissues was also
detected by immunostaining and Western blot. We found that naı ¨ve ZDF rats developed hyperglycemia steadily. These ZDF
rats showed a strong positive correlation between longer immobility time and higher plasma HbAlC level. Long term taVNS
treatment simultaneously prevented the development of depression-like behavior and progression of hyperglycemia in ZDF
rats. The expression of IR in various tissues of naı ¨ve ZDF rats is lower than in naı ¨ve ZL and long-term taVNS treated ZDF rats.
Collectively, our results indicate that in ZDF rats, i) depression and T2D develop simultaneously, ii) immobility time and
HbAlc concentrations are highly and positively correlated, iii) a low expression of IR may be involved in the comorbidity of
depression and T2D, and iv) taVNS is antidiabetic and antidepressive possibly through IR expression upregulation.
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Introduction
Type 2 diabetes (T2D) is a metabolic disorder characterized by
high blood sugar level in the context of insulin resistance, in which
body cells have lost the ability to respond adequately to relatively
normal levels of insulin [1]. Rates of T2D have been increasing
markedly since 1960 in parallel with obesity. To make things
worse, ongoing epidemiological studies estimate that greater than
60% of adult US population may be categorized as either
overweight or obese, which is a major risk factor of T2D [2,3].
Furthermore, there is a growing appreciation that the complica-
tions of obesity extend to the central nervous system (CNS) and
may result in increased risk for neurological comorbidities such as
depressive illness. Depression is a state of low mood that affects
thoughts, behavior, feelings and sense of well-being. Patients with
depression may lose interest of life and contemplate, attempt, or
commit suicide [4].
During the past two decades, studies found an increased
prevalence of depression in the diabetic population, and vice versa
[4,5]. Despite the high prevalence of and common comorbidity
between depression and T2D [6,7], the mechanism behind the
phenomena is unclear. The increasing burden of T2D and major
depressive disorder makes the search for an extended understand-
ing of etiology and for the development of additional treatments
highly significant.
As a kind of complementary and alternative medicine,
acupuncture is generally accepted as a beneficial, well-tolerated,
and safe monotherapy for depression in animal models, clinical
patients, and eldercare facility residents [8–11]. Specifically, the
taVNS, which stimulates the afferent auricular branches of vagus
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nucleus further project, mono- or multi-synaptically, to the limbic
and the autonomic nervous system structures, including the pineal
gland, ventral tegmental area, the hypothalamus, amygdala,
anterior cingulate cortex, nucleus accumbens, and the lateral
prefrontal cortex [12]. Fibers from the solitary nucleus also project
to the locus ceruleus and dorsal raphe nucleus, respectively major
nuclei related to noradrenergic and serotonergic innervations of
the entire brain cortex. It is clear that the serotonergic,
dopaminergic, and noradrenergic systems are commonly involved
in the pathophysiology of depression and in the neuromechanisms
of action of antidepressants [12]. Acupuncture has also been
shown to decrease blood glucose level in T2D [13] and is
beneficial in the treatment of obesity [14,15], which is a primary
cause of T2D in genetically predisposed people [3].
Based on the existence of overt depression in Zucker diabetic
fatty (ZDF, fa/fa) rats [12] as well as the increasingly prevalent and
high comorbidity of obesity and depression [16], in this study we
used ZDF rats as a diabetes and depression rodent model to
explore the correlation of the illnesses, the antidiabetic and
antidepressive effectiveness of taVNS, and focused on a possible
involvement of IR expression in the mechanism of the comorbidity
between T2D and depression.
Materials and Methods
Animal model
Male ZDF rats (n=14) and ZL littermates (n=13) were
purchased from Vital River Laboratories International Inc.
(Beijing, China). Littermates from the same or foster mother were
housed in one large cage with water and normal food pellets
available ad libitum except during taVNS session. Animal room
was maintained at 2261uC and artificially illuminated from 7:00
A.M. to 7:00 P.M. There was no previous handling of the rats.
Rats entered the experimental procedure at 6 weeks of age and
were separated into ZDF and ZL groups according to the
genotype, the appearance, and the first tested glucose concentra-
tion. The initial body weight was 175615 grams for ZDF and
130610 for ZL rats. The rats were raised in groups of three to
four. The cages and beddings were changed every other day. The
person in charge of the animal’s welfare was also the same person
who carried out the experiments. The experimental protocol was
approved by Institutional Animal Care and Use Committee in
China Academy of Chinese Medical Sciences.
Figure 1. Blood glucose change in naı ¨ve and taVNS treated rats. Showing the development of hyperglycemia in ZDF rats with or without the
taVNS treatment (a) and the effect of taVNS in ZL rats. ZDF, naı ¨ve ZDF rats; ZL, naı ¨ve ZL rats; taVNS, transcutaneous auricular vagus nerve stimulation;
AMS, auricular margin stimulation; Bas, baseline; W1-5, week 1 to week 5 of the experiment. *, **, ***, P,0.05, 0.01, 0.001 vs. Bas; #, ###,P ,0.05,
0.001 vs. naı ¨ve rats, respectively.
doi:10.1371/journal.pone.0112066.g001
Figure 2. Correlation of depressive behavior and glucose metabolism dysfunction. Showing the immobility time of rats in FST (a) and the
HbAlc concentration (b) on day 35 and their correlation in linear regression. ZL, naı ¨ve ZL rats; ZL-VS, taVNS in ZL rats; ZDF, naı ¨ve ZDF rats; ZDF-VS,
taVNS in naı ¨ve ZDF rats. *, **, P,0.05, 0.01 vs. ZL; #, ##, P,0.05, 0.01 vs. ZDF, respectively.
doi:10.1371/journal.pone.0112066.g002
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By using Ascensia Breeze Blood Glucose Monitoring System
(Newbury, Berks, UK), the progression of T2D was determined by
weekly tested non-fasted blood glucose concentration from week 0
(baseline) to week 5. In an electronic stimulation experiment room,
a rat was tenderly put into the plexiglass box linked to the
inhalation anesthesia system. Under 2% isoflurane anesthesia,
glucose concentration was tested from tail tip blood immediately
before taVNS session. The test range was 0.6–33.3 mmol/L. Any
concentration over the testing limit was recorded as 33.3 mmol/L
for statistical purposes.
Administration of taVNS
All the time points recorded in this study are in accordance with
the taVNS occurrences, i.e. the beginning of taVNS is day 1. For
taVNS, under 2% isoflurane inhalation anesthesia, two opposite
magnetic electrodes (+/2) were placed over the right side
auricular concha region, inside and outside respectively so that
electronic current can conduct through the tissue, including the
vagus nerve fibers. Saline was applied between an electrode and
the skin to improve electronic conduction. A 30 min taVNS
procedure at a frequency of 2/15 Hz (2 and 15 Hz, switched
every second) and an intensity of 2 mA was administered once
daily via an electrical stimulator (HANS-100, Nanjing, China).
The parameters had been proven effective previously [17]. The
procedures were performed in the afternoon after blood glucose
test and blood sample collection at designed time points, for 34
consecutive days for ZDF rats and 27 days for ZL rats. Because the
glucose concentration of ZL rats showed no detectable fluctuations
for over two weeks, the experimental period in them was one week
shorter for the benefit of rats. Auricular margin was used as sham
acupoint.
ELISA
Concentration of plasma HbAlc was evaluated upon sacrifice at
day 28 for ZL rats and day 35 for ZDF rats. ELISA kits were
purchased from R&D System (Beijing, China) and analyzed by
Huanya Biomedicine Technology Co. LTD (Beijing, China). The
results were read using a microplate reader (Multiskan MK3,
Thermo Scientific, Beijing, China) at wavelengths of 450 nm.
Forced swimming test (FST)
The FST was modified based on the methods previously used in
our study [18,19] but omitted the pre-test session, which we found
to be a confounding factor to the final results such that the pre-
tested rats tended to stay still in the formal test and the immobility
time was extremely prolonged to obscure the difference between
animal groups. Briefly, a rat was placed in a clear plastic tank
(45635660 cm) containing 30 cm of water (2460.5uC) for 5 min.
The total duration of non-swimming time within the 5-min session
was recorded with a stopwatch as immobility score (in seconds)
and compared among groups. A rat was judged to be non-
swimming when no attempt was made to escape the tank and the
rat was hunched forward (a floating position). Both ZL and ZDF
rats underwent the same test procedure. Following FST session,
the rat was removed from the water tank, dried with a towel, and
returned to the home cage. All tests took place between 2 PM and
5 PM in a behavior testing room and were observed by the
experimenter who blinded to the group assignment in order to
minimize between-experimenter and between-session variations.
Immunohistochemical staining
Rats were anesthetized with sodium pentobarbital and trans-
cardially perfused with 200 ml of saline followed by 200–300 ml of
cold 4% paraformaldehyde in 0.1 M phosphate buffer (PB). Brain
Table 1. Immobility time in FST on day 35.
Rat group Naı ¨ve ZDF ZDF-taVNS Naı ¨ve ZL ZL-taVNS
Mean 87.833 36.625 40 39.667
Standard deviation (SD) 28.032 28.096 29.878 23.304
Sample size (N) 6 8 7 6
Std. error of mean(SEM) 11.444 9.934 11.292 9.514
Lower 95% conf. limit 58.411 13.312 12.367 15.207
Upper 95% conf. limit 117.26 60.118 67.633 64.126
Tukey-Kramer multiple comparisons test P value vs. Naı ¨ve ZDF ,0.01 ,0.05 ,0.05
doi:10.1371/journal.pone.0112066.t001
Table 2. HbAlc concentration on day 35.
Rat groups Naı ¨ve ZDF ZDF-taVNS Naı ¨ve ZL ZL-taVNS
Mean 219.57 170.94 157.68 172.91
Standard deviation (SD) 27.465 17.187 23.461 35.620
Sample size (N) 6 8 7 6
Std. error of mean(SEM) 11.213 6.076 8.867 14.542
Lower 95% conf. limit 190.74 156.57 135.98 135.53
Upper 95% conf. limit 248.40 185.31 179.38 210.30
Tukey-Kramer multiple comparisons test P value vs. Naı ¨ve ZDF ,0.05 ,0.01 ,0.05
doi:10.1371/journal.pone.0112066.t002
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for 2 hr, and kept in 30% sucrose in 0.1 M PB until sank to the
bottom. Tissues were then mounted in OCT compound and
frozen on dry ice.
Brain (30 mm) sections were cut on a cryostat, mounted serially
onto microscope slides, and stored at 280uC. Immunohistochem-
ical staining was used to detect IR (mouse monoclonal, 1:1000;
Abcam, Cambridge, MA), NeuN (neuronal marker, rabbit
monoclonal, 1:1000; Abcam, Cambridge, MA), and GFAP
(astrocyte marker, chicken polyclonal, 1:1000; Abcam, Cam-
bridge, MA). Sections were blocked with 1% goat serum in 0.3%
Triton for 1 hr at room temperature and incubated overnight at
4uC with a primary antibody. For controls, a primary antibody
was omitted. The sections were then incubated for 1 hr at room
temperature with corresponding FITC- or CY3-conjugated
secondary antibody (1:200; Jackson ImmunoResearch, West
Grove, PA). Four to six nonadjacent brain or spinal sections were
randomly selected, analyzed using a LEXT OLS4000 3D Laser
Measuring Microscope (Olympus), recorded using a digital
camera, and processed using Adobe Photoshop.
Western blot
The expression of IR in hypothalamus, liver, and skeletal
muscle was tested by Western blot. Rats (n=3 each group) were
decapitated under anesthesia and samples were collected. The
segments were homogenized in SDS sample buffer containing a
mixture of proteinase inhibitors (Sigma). Protein samples were
separated on SDS-PAGE gel (4–15% gradient gel; Bio-Rad,
Hercules, CA) and transferred to polyvinylidene difluoride filters
(Millipore, Bedford, MA). The filters were blocked with 3% milk
and incubated overnight at 4uC with a primary antibody of IR
(mouse monoclonal, 1:4000; Abcam, Cambridge, MA) for 1 hr at
room temperature with HRP-conjugated secondary antibody
(1:7000; Abcam, Cambridge, MA). The blots were visualized in
ECL solution (NEN, Boston, MA) for 1 min and exposed onto
hyperfilms (Amersham Biosciences) for 1–10 min. The blots were
then incubated in a stripping buffer (67.5 mM Tris, pH 6.8, 2%
SDS, and 0.7% b-mercaptoethanol) for 30 min at 50uC and
reprobed with a polyclonal rabbit anti-GADPH antibody
(1:20,000; Abcam, Cambridge, MA) as loading control. Western
analysis was made in triplicates. The density of specific bands was
measured with a computer-assisted imaging analysis system and
normalized against loading controls. Differences were compared
using One-way ANOVA.
Statistical analysis
By running GraphPad InStat version 3 for Windows, raw data
of glucose concentration, immobility, and ELISA results were
compared using repeated measure One-way ANOVA to detect
differences among treatment groups, followed by Tukey-Kramer
Multiple Comparisons Test to determine sources of differences.
Data were presented as mean 6 standard deviation. Differences
were considered to be statistically significant at the level of
a=0.05. The correlation between HbAlc concentration and
immobility time was acquired by linear regression.
Results
The development of hyperglycemia in naı ¨ve ZDF rats and
the preventive effect of taVNS on the progression
As determined by the weekly blood glucose concentration, the
naı ¨ve ZDF rats (n=6) developed hyperglycemia steadily with age,
in contrast with a euglycemia in taVNS treated ZDF rats (Fig. 1a,
n=6). The results were also compared with that of ZL rats, naı ¨ve,
and taVNS or AMS (auricular margin stimulation) treated rats
(n=4, each), in which no hyperglycemia developed (Fig. 1b).
Effects of long term taVNS on depression-like behavior
and plasma HbAlc concentration in rats
As determined by the FST on day 35, the naı ¨ve ZDF rats
performed poorly in the tank with an immobility time of
87.83628.03 (mean 6 SD, n=6). This immobility time is much
longer than that of ZL rats and of taVNS treated ZDF rats (One-
way ANOVA P=0.006, Fig. 2a, Table 1). Simultaneously, the
HbAlc concentration in taVNS treated rats is significantly lower
than that in naı ¨ve ZDF rats (One-way ANOVA P=0.0019,
Fig. 2b, Table 2).
The antidepressive and antidiabetic effects of taVNS were also
evaluated in ZL rats. While it is antidepressive and antidiabetic in
ZDF rats, the taVNS shows no effects in ZL rats, possibly due to
normal swimming time and glucose metabolism condition in the
latter (P.0.05, Fig. 2a, Table 1).
The correlation between the immobility time and the HbAlc
concentration on day 35 is shown in Fig. 2c. As analyzed in linear
regression, a strong positive correlation exists between the
immobility time and the HbAlc concentration in ZDF rats
(y=153.244+0.685x), in contrast to ZL rats in which a weak
negative correlation (y=173.73220.231x) is shown (Fig. 2C,
Table 3). Alternatively, a higher HbAlc concentration can
predicate a longer immobility time in ZDF rats (y=2108.276+
0.87x), in contrast to that in ZL rats (y=69.65520.186x).
IR expression in naı ¨ve ZDF and the effect of taVNS on the
expression of IR
As detected by immunostaining and by Western blots, the
expression of IR in the hypothalamus, liver, and skeletal muscle is
lower in naı ¨ve ZDF rats than that in ZL. However, in the same
tissues of the taVNS treated ZDF rats, the IR expression was
upregulated (Fig. 3).
In double labelling immunofluorescence brain sections, the IR
was colocalized with NeuN (Fig. 4a–d) but not GFAP (Fig. 4e–h),
indicating that the IR-immunopositive cells in the brain is
Table 3. Correlations between HbAlc level and immobility time in FST on day 35.
Rat groups ZDF ZL
Estimated HbAlc level from immobility time y=153.244+0.685xy =173.73220.231x
Estimated immobility time from HbAlc level y=2108.276+0.87xy =69.65520.186x
Correlation R=0.757 R=20.207
P value P=0.002 P=0.497
doi:10.1371/journal.pone.0112066.t003
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neurons.
Discussion
In this study we report that the ZDF rats not only develop
diabetes innately, they also develop depressive-like behaviors and
that taVNS simultaneously prevent the progression of depressive
behavior and hyperglycemia in ZDF rats.
A number of epidemiological studies have established a link
between insulin resistance and the prevalence of depression.
However, at this time it is not conclusive as to whether insulin
resistance induces depression or the opposite. Although a study
found that downregulation of hypothalamic insulin receptor
Figure 3. Expression of insulin receptor in various tissues of rats. (a, b) Immunofluorescent results showing the expression of insulin receptor
(IR) in amygdala of naı ¨ve ZDF rats (a) and of ZDF rats treated for 5 consecutive weeks with daily half hour taVNS treatment (b). Arrow head, IR-
immunopositive neurons. Bar, 100 mm. (c–h) Western blot results showing the expression of insulin receptor in hypothalamus (c, d), liver (e, f), and
skeletal muscle (g, h) of naı ¨ve rats, or rats treated with taVNS for 34 consecutive days. ZL, naı ¨ve ZL rats; ZDF, naı ¨ve ZDF rats; taVNS, auricular vagus
electronic stimulation. n=3 each group, Western blot triplicated for each sample. *,** P,0.05, 0.01 vs. ZL; #,## P,0.05, 0.01 vs. ZDF.
doi:10.1371/journal.pone.0112066.g003
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found that the occurrence of depression precede the onset of
diabetes [22], and that insulin resistance can be reversed by
antidepressant treatment [23]. Meanwhile, not only are depressive
symptoms a risk factor for the development of T2D, they have also
been shown to contribute to hyperglycemia, diabetic complica-
tions, functional disability and all-cause mortality among diabetic
patients [4,5]. Taken together, these reports indicate that the
depression and insulin resistance may be bidirectional in cause.
Leptin is an adipocytokine or hormone secreted by white
adipose tissue. Mediated through leptin receptor, leptin works
together with insulin to decrease blood glucose level. Genetically,
ZDF rats are leptin receptor deficient in and resistant to leptin,
and therefor develop T2D with hyperglycemia and hyperinsulin-
emia. It is reported that hyperinsulinemia increases sympathetic
nerve activity in obesity and diabetes [24] and that an increased
sympathetic tone is closely related to depression [4]. From this
point of view, we propose that depression in ZDF rats might be a
result of hyperinsulinemia and glucose metabolism dysfunction in
the CNS and that antidepressive effect of taVNS may be elicited
by decreasing sympathetic tone or increasing parasympathetic
activity; in turn, this antidepressive effect would also be helpful in
reducing the insulin resistance. Indeed, the activity of the vagus
nerve is negatively associated with risk factors such as stress and
smoking, morbidity and mortality, and accordingly, taVNS which
directly stimulates the afferent vagus branches at the auricular
concha region, has been used in the therapeutic intervention in
depression and epilepsy [23,25,26].
IR is necessary for the insulin to activate the intracellular
signaling system both in the CNS and the peripheral cells. It is
known that insulin performs unique functions within the CNS
[27]. Produced nearly exclusively by the pancreas, insulin crosses
the blood-brain barrier using a saturable transporter, affecting
feeding and cognition through CNS mechanisms largely indepen-
dent of glucose utilization. While peripheral insulin acts primarily
as a metabolic regulatory hormone, CNS insulin has an array of
effects on the brain that may more closely resemble the actions of
the ancestral insulin molecule [28,29]. Resistance to insulin action
within the CNS may be in parallel or associated with peripheral
insulin resistance, but it is also possible that variable insulin
resistance syndromes exist so that resistance at one tissue may be
independent from that of others. In this study, the expression of IR
was low in various tissues including the hypothalamus, the liver,
and the skeletal muscle of naı ¨ve ZDF rats and it was upregulated
in taVNS treated rats. These results, while indicating that IR is
involved in the pathogenesis mechanism of depression and T2D,
also support the theory that taVNS is helpful in ameliorating both
the depressive and the diabetic syndromes in these rats. It is very
likely that, the upregulated expression of IR in the peripheral
tissue such as liver and skeletal muscle is related to the
amelioration of T2D, and in the CNS it is beneficial in the
antidepressive effect of taVNS.
Although we demonstrate that taVNS is antidiabetic and
antidepressive in ZDF rats, it has limited efficiency in ZL rats, a
similar phenomenon as in melatonin treated experimental animals
[30]. This may be due to a reduced parasympathetic activity in
ZDF but not ZL rats. Further investigation would be focused on
detection of the secretion change of hormones that are easily
affected by the autonomic nervous system. One such hormone
candidate is melatonin, which is related to both depression
[19,20,31,32] and T2D [33–35] with nonsufficient concentration
in the circulating blood.
Conclusions
Our results show that downregulated expression of IR and the
compensatory hyperinsulinemia may be involved in the comor-
bidity between depression and T2D and that taVNS has a
potential antidiabetic and antidepressive in ZDF rats.
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